Yuki Tomonaga

1.9k total citations
21 papers, 537 citations indexed

About

Yuki Tomonaga is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yuki Tomonaga has authored 21 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Nephrology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yuki Tomonaga's work include Chronic Kidney Disease and Diabetes (5 papers), Dialysis and Renal Disease Management (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Yuki Tomonaga is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Dialysis and Renal Disease Management (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Yuki Tomonaga collaborates with scholars based in Switzerland, United States and Austria. Yuki Tomonaga's co-authors include Matthias Schwenkglenks, Alena M. Pfeil, Thomas D. Szucs, Milo A. Puhan, Henock G. Yebyo, Dominik Menges, Lorenz Risch, Patrice M. Ambühl, Michaela Barbier and Sarah R. Haile and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Critical Care.

In The Last Decade

Yuki Tomonaga

21 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Tomonaga Switzerland 12 198 104 82 82 73 21 537
Dashiell Gantner Australia 17 89 0.4× 92 0.9× 170 2.1× 123 1.5× 157 2.2× 37 744
Adriano Luiz Ammirati Brazil 9 89 0.4× 28 0.3× 24 0.3× 85 1.0× 63 0.9× 16 527
Lucas Lauder Germany 15 123 0.6× 118 1.1× 16 0.2× 138 1.7× 26 0.4× 79 856
Saeed K. Shaffi United States 10 73 0.4× 32 0.3× 32 0.4× 80 1.0× 38 0.5× 24 755
Jayoun Kim South Korea 14 114 0.6× 33 0.3× 13 0.2× 159 1.9× 30 0.4× 70 665
Enrique Rodilla Spain 16 55 0.3× 91 0.9× 27 0.3× 148 1.8× 95 1.3× 88 780
Vito D’Agnano Italy 12 176 0.9× 20 0.2× 49 0.6× 33 0.4× 89 1.2× 40 713
R.E. Roller Austria 14 60 0.3× 45 0.4× 20 0.2× 139 1.7× 113 1.5× 37 552
Susan Connolly United Kingdom 15 98 0.5× 98 0.9× 12 0.1× 216 2.6× 75 1.0× 38 1.1k

Countries citing papers authored by Yuki Tomonaga

Since Specialization
Citations

This map shows the geographic impact of Yuki Tomonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Tomonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Tomonaga more than expected).

Fields of papers citing papers by Yuki Tomonaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Tomonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Tomonaga. The network helps show where Yuki Tomonaga may publish in the future.

Co-authorship network of co-authors of Yuki Tomonaga

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Tomonaga. A scholar is included among the top collaborators of Yuki Tomonaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Tomonaga. Yuki Tomonaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomonaga, Yuki, et al.. (2023). Cost‐effectiveness of risk‐based low‐dose computed tomography screening for lung cancer in Switzerland. International Journal of Cancer. 154(4). 636–647. 7 indexed citations
2.
Menges, Dominik, Henock G. Yebyo, Sarah R. Haile, et al.. (2022). Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment. European Urology Oncology. 5(6). 605–616. 50 indexed citations
3.
Barbier, Michaela, Yuki Tomonaga, Dominik Menges, et al.. (2022). Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer. PLoS ONE. 17(11). e0277282–e0277282. 8 indexed citations
4.
Tomonaga, Yuki, Dominik Menges, Henock G. Yebyo, et al.. (2022). Early mobilisation and rehabilitation in Swiss intensive care units: a cross-sectional survey. Swiss Medical Weekly. 152(304). w30125–w30125. 6 indexed citations
5.
Tomonaga, Yuki, et al.. (2021). Productivity losses due to influenza and influenza-like illness in Switzerland: results of the Swiss Sentinel Surveillance Network in a non-pandemic era. Swiss Medical Weekly. 151(3334). w30022–w30022. 4 indexed citations
6.
7.
8.
Speich, Benjamin, Nadine Schur, Belinda von Niederhäusern, et al.. (2019). Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation. PLoS ONE. 14(1). e0210669–e0210669. 9 indexed citations
9.
Gloy, Viktoria, Andreas U. Monsch, Reto W. Kressig, et al.. (2019). Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis. Swiss Medical Weekly. 149(2526). w20093–w20093. 25 indexed citations
10.
Blank, Patricia R., Yuki Tomonaga, Thomas D. Szucs, & Matthias Schwenkglenks. (2019). Economic burden of symptomatic iron deficiency – a survey among Swiss women. BMC Women s Health. 19(1). 39–39. 12 indexed citations
11.
Ademi, Zanfina, Yuki Tomonaga, Dominik Glinz, et al.. (2018). Adaptation of cost-effectiveness analyses to a single country: the case of bariatric surgery for obesity and overweight. Swiss Medical Weekly. 148(2324). w14626–w14626. 29 indexed citations
12.
Tomonaga, Yuki, Kevin ten Haaf, Thomas Frauenfelder, et al.. (2018). Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking—A modelling study. Lung Cancer. 121. 61–69. 51 indexed citations
13.
Risch, Martin, Lorenz Risch, Mette-Triin Purde, et al.. (2016). Association of the cystatin C/creatinine ratio with the renally cleared hormones parathyroid hormone (PTH) and brain natriuretic peptide (BNP) in primary care patients: a cross-sectional study. Scandinavian Journal of Clinical and Laboratory Investigation. 76(5). 379–385. 8 indexed citations
14.
Schwarz, Albin, et al.. (2016). Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy. PLoS ONE. 11(7). e0159942–e0159942. 16 indexed citations
15.
Tomonaga, Yuki, Lorenz Risch, Thomas D. Szucs, & Patrice Max Ambuehl. (2013). The Prevalence of Chronic Kidney Disease in a Primary Care Setting: A Swiss Cross-Sectional Study. PLoS ONE. 8(7). e67848–e67848. 18 indexed citations
16.
Tomonaga, Yuki, Martin Hatzinger, Edith Holsboer‐Trachsler, et al.. (2013). The Economic Burden of Depression in Switzerland. PharmacoEconomics. 31(3). 237–250. 40 indexed citations
17.
Pfeil, Alena M., et al.. (2012). A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clinical Nutrition. 32(2). 213–223. 112 indexed citations
18.
Tomonaga, Yuki, et al.. (2012). Insights on urinary NGAL obtained in a primary care setting. Clinica Chimica Acta. 413(7-8). 733–739. 17 indexed citations
19.
Tomonaga, Yuki, Félix Gutzwiller, Thomas F. Lüscher, et al.. (2011). Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial. BMC Family Practice. 12(1). 12–12. 41 indexed citations
20.
Szucs, Thomas D., B. Waeber, & Yuki Tomonaga. (2009). Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective. Journal of Human Hypertension. 24(2). 117–123. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dashiell Gantner Breakdown of academic impact, for papers by Adriano Luiz Ammirati Breakdown of academic impact, for papers by Lucas Lauder Breakdown of academic impact, for papers by Saeed K. Shaffi Breakdown of academic impact, for papers by Jayoun Kim Breakdown of academic impact, for papers by Enrique Rodilla Breakdown of academic impact, for papers by Vito D’Agnano Breakdown of academic impact, for papers by R.E. Roller Breakdown of academic impact, for papers by Susan Connolly
Rankless by CCL
2026